NewsSource: EClinCloud

EClinCloud Service Overview | Scale Management

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image



Rating scales are a measurement and assessment tool commonly used in clinical practice and are essential for assessing disease severity and conducting objective diagnosis and treatment. Compared with other examination methods, scales are simpler and more accurate to use, and have therefore become an important standard for measuring treatment effects in evidence-based medical research.






1

Pain Points and Challenges in Scale Management for Clinical Trials in China

Currently, most scales used in clinical research are introduced from abroad, creating many pain points and challenges for scale management in clinical trials in China.


1

Prone to infringement and compliance issues

2

Difficulty in obtaining copyrights

3

Long time investment and high costs

4

Broad communication scope and complex content


2

What Services Does EClinCloud Scale Management Include?


1

Due diligence

2

Copyright acquisition

3

Translation and linguistic validation (if applicable)

4

Scale delivery

5

Project management and in-process change management




3

Why Choose EClinCloud Scale Management Services?

Article image

A specialized scale services team handles copyright due diligence, with a project-dedicated medical manager providing end-to-end follow-up support

Extensive project implementation experience, with established working relationships with multiple scale copyright holders

In-depth collaboration with experts across diverse fields to provide high-quality responsiveness for scale guidance and rater training

Our eCOA product supports scale digitization, with extensive experience in electronic scale migration




About EClinCloud

EClinCloud is a technology company focused on clinical research and development, offering an integrated, interconnected, all-in-one clinical trial cloud platform (including solutions such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis within technology products and programs including eCOA, CTMS, eTMF, EDC, RTSM, and RM) alongside clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system and ophthalmology). By combining cutting-edge technology with life data, EClinCloud is building a globally leading, patient-centric SaaS cloud platform for clinical evidence support to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.







Article image

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.